Jingshu Tang

Title: Innovations of Jingshu Tang in Biopharmaceuticals

Introduction

Jingshu Tang is a notable inventor based in Beijing, China, recognized for his contributions to the field of biopharmaceuticals. He holds two patents that focus on innovative drug targets and treatment methods for various diseases. His work has significant implications for the diagnosis and treatment of epithelial tumors and central nervous system diseases.

Latest Patents

One of Jingshu Tang's latest patents is titled "IgG epitope and applications thereof as a drug target." This invention provides insights into the C1 domain of non-B cell-derived IgG, highlighting the importance of N-glycosylated sialic acid modification at the Asn162 site. The functionality of this antigen is dependent on the sialylation of the site, which is crucial for its role as a drug target in the preparation of drugs for diagnosing and treating epithelial tumors. Additionally, the patent discusses the role of sialyltransferase ST3GAL4 as a potential drug target for tumor therapeutic drugs. Another significant patent is "Thiazolopyrimidinone compounds and preparation methods and use thereof," which details the structural aspects of thiazolopyrimidinone compounds and their application in manufacturing medications for central nervous system diseases.

Career Highlights

Jingshu Tang has worked with prominent organizations such as Beijing Sig Biopharmaceutical Technology Co., Ltd. and Peking University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Jingshu Tang has collaborated with notable colleagues, including Xiaoyan Qiu and Zhi Yang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the biopharmaceutical field.

Conclusion

Jingshu Tang's innovative patents and career achievements underscore his significant role in advancing biopharmaceutical research. His contributions are paving the way for new therapeutic approaches to combat serious health conditions.